A novel bioavailable curcumin-galactomannan complex modulates the genes responsible for the development of chronic diseases in mice: A RNA sequence analysis
Akay’s gene-regulating CurQfen shows potential for chronic inflammatory diseases, study finds
A mouse study conducted by researchers at the Indian Institute of Technology (IIT) has found that Akay’s CurQfen, a curcumin-fenugreek supplement, shows potential in treating and preventing inflammation caused by chronic disease. Notably, CurQfen was found to act as a prophylactic agent, upregulating health-guarding genes and down-regulating disease-causing genes.
Read More: Click here
